| Print
Anika Therapeutics (ANIK)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Address
32 Wiggins Avenue
Bedford
MA
USA
01730
Telephone
+1 781 4579000
Forecast key dates
| Name | Key Date |
|---|---|
| Anika Therapeutics Inc First Quarter Earnings Conference Call for 2027 | 2027-04-29T08:30:00 |
| Anika Therapeutics Inc First Quarter Earnings Results for 2027 | 2027-04-29T00:00:00 |
| Anika Therapeutics Inc Annual Report for 2026 | 2027-03-03T00:00:00 |
| Anika Therapeutics Inc Fourth Quarter Earnings Conference Call for 2026 | 2027-02-26T08:30:00 |
| Anika Therapeutics Inc Fourth Quarter Earnings Results for 2026 | 2027-02-26T00:00:00 |
| Anika Therapeutics Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-05T08:30:00 |
| Anika Therapeutics Inc Third Quarter Earnings Results for 2026 | 2026-11-05T00:00:00 |
| Anika Therapeutics Inc Second Quarter Earnings Conference Call for 2026 | 2026-07-30T08:30:00 |
| Anika Therapeutics Inc Second Quarter Earnings Results for 2026 | 2026-07-30T00:00:00 |
| Anika Therapeutics Inc Annual General Meeting for 2026 | 2026-06-19T08:30:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.